These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD; Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749 [TBL] [Abstract][Full Text] [Related]
5. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Madonna R; Van Laake LW; Davidson SM; Engel FB; Hausenloy DJ; Lecour S; Leor J; Perrino C; Schulz R; Ytrehus K; Landmesser U; Mummery CL; Janssens S; Willerson J; Eschenhagen T; Ferdinandy P; Sluijter JP Eur Heart J; 2016 Jun; 37(23):1789-98. PubMed ID: 27055812 [TBL] [Abstract][Full Text] [Related]
6. Reparative resynchronization in ischemic heart failure: an emerging strategy. Yamada S; Terzic A Expert Opin Biol Ther; 2014 Aug; 14(8):1055-60. PubMed ID: 24840208 [TBL] [Abstract][Full Text] [Related]
7. Regenerating new heart with stem cells. Anversa P; Kajstura J; Rota M; Leri A J Clin Invest; 2013 Jan; 123(1):62-70. PubMed ID: 23281411 [TBL] [Abstract][Full Text] [Related]
8. Current outlook of cardiac stem cell therapy towards a clinical application. Takashima S; Tempel D; Duckers HJ Heart; 2013 Dec; 99(23):1772-84. PubMed ID: 23525708 [No Abstract] [Full Text] [Related]
9. Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue. Mayorga M; Finan A; Penn M Stem Cell Rev Rep; 2009 Mar; 5(1):51-60. PubMed ID: 19184567 [TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3. Wolfien M; Klatt D; Salybekov AA; Ii M; Komatsu-Horii M; Gaebel R; Philippou-Massier J; Schrinner E; Akimaru H; Akimaru E; David R; Garbade J; Gummert J; Haverich A; Hennig H; Iwasaki H; Kaminski A; Kawamoto A; Klopsch C; Kowallick JT; Krebs S; Nesteruk J; Reichenspurner H; Ritter C; Stamm C; Tani-Yokoyama A; Blum H; Wolkenhauer O; Schambach A; Asahara T; Steinhoff G EBioMedicine; 2020 Jul; 57():102862. PubMed ID: 32629392 [TBL] [Abstract][Full Text] [Related]
11. Regenerative medicine approach to repair the failing heart. Lionetti V; Ventura C Vascul Pharmacol; 2013 Mar; 58(3):159-63. PubMed ID: 23337493 [TBL] [Abstract][Full Text] [Related]
12. Mechanical unloading and cell therapy have a synergistic role in the recovery and regeneration of the failing heart. Ibrahim M; Rao C; Athanasiou T; Yacoub MH; Terracciano CM Eur J Cardiothorac Surg; 2012 Aug; 42(2):312-8. PubMed ID: 22378852 [TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. Yeo C; Mathur A Regen Med; 2009 Jan; 4(1):119-27. PubMed ID: 19105621 [TBL] [Abstract][Full Text] [Related]
14. Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells. Ott HC; Davis BH; Taylor DA Semin Thorac Cardiovasc Surg; 2005; 17(4):348-60. PubMed ID: 16428043 [TBL] [Abstract][Full Text] [Related]
15. Stem cells transplantation combined with long-term mechanical circulatory support enhances myocardial viability in end-stage ischemic cardiomyopathy. Anastasiadis K; Antonitsis P; Doumas A; Koliakos G; Argiriadou H; Vaitsopoulou C; Tossios P; Papakonstantinou C; Westaby S Int J Cardiol; 2012 Mar; 155(3):e51-3. PubMed ID: 21852003 [No Abstract] [Full Text] [Related]
16. Strategies to Enhance the Effectiveness of Adult Stem Cell Therapy for Ischemic Heart Diseases Affecting the Elderly Patients. Khatiwala R; Cai C Stem Cell Rev Rep; 2016 Apr; 12(2):214-23. PubMed ID: 26779896 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy? Sanina C; Hare JM Circ Res; 2015 Jul; 117(3):229-33. PubMed ID: 26185208 [TBL] [Abstract][Full Text] [Related]
20. Towards regenerative therapy for cardiac disease. Ptaszek LM; Mansour M; Ruskin JN; Chien KR Lancet; 2012 Mar; 379(9819):933-942. PubMed ID: 22405796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]